CSF2 and neoplasm: We also demonstrated efficacy with a combinatorial strategy consisting of a GM-CSF-secreting tumor cell vaccine and ICB therapy (anti-PD-1 and anti-CTLA-4) in mice bearing ID8-VEGF-expressing tumor.